0001213900-19-009295.txt : 20190521 0001213900-19-009295.hdr.sgml : 20190521 20190521135801 ACCESSION NUMBER: 0001213900-19-009295 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190515 FILED AS OF DATE: 20190521 DATE AS OF CHANGE: 20190521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bison Capital Holding Co Ltd CENTRAL INDEX KEY: 0001593415 STATE OF INCORPORATION: F4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38120 FILM NUMBER: 19841823 BUSINESS ADDRESS: STREET 1: 609-610, 21ST CENTURY TOWER STREET 2: 40 LIANGMAQIAO RD, CHAOYANG DISTRICT CITY: BEIJING STATE: F4 ZIP: 100016 BUSINESS PHONE: 8618610840084 MAIL ADDRESS: STREET 1: 609-610, 21ST CENTURY TOWER STREET 2: 40 LIANGMAQIAO RD, CHAOYANG DISTRICT CITY: BEIJING STATE: F4 ZIP: 100016 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: XYNOMIC PHARMACEUTICALS HOLDINGS, INC. CENTRAL INDEX KEY: 0001697805 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: D8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 609-610 21ST CENTURY TOWER STREET 2: 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT CITY: BEIJING STATE: F4 ZIP: 100016 BUSINESS PHONE: 9493506999 MAIL ADDRESS: STREET 1: 609-610 21ST CENTURY TOWER STREET 2: 40 LIANGMAQIAO ROAD, CHAOYANG DISTRICT CITY: BEIJING STATE: F4 ZIP: 100016 FORMER COMPANY: FORMER CONFORMED NAME: Bison Capital Acquisition Corp. DATE OF NAME CHANGE: 20170621 FORMER COMPANY: FORMER CONFORMED NAME: Bison Capital Acquisition Corp DATE OF NAME CHANGE: 20170209 4 1 ownership.xml OWNERSHIP DOCUMENT X0306 4 2019-05-15 0 0001697805 XYNOMIC PHARMACEUTICALS HOLDINGS, INC. XYN 0001593415 Bison Capital Holding Co Ltd SUITE 3306, K. WAH CENTRE, 1010 MIDDLE HUAIHAI ROAD SHANGHAI F4 200031 CHINA 0 0 0 1 Former 10% more owner Common Stock, par value $0.0001 per share 2019-05-15 4 P 0 108980 A 1628580 D Warrants 11.5 2019-05-15 4 P 0 25000 11.50 A Common Stock 25000 225937 D In connection with the closing of a business combination with Xynomic Pharmaceuticals, Inc., Bison Capital Holding Company Limited, a Cayman Islands company ("Bison Capital"), purchased 13,793 shares (the "Backstop Shares") of common stock of Bison Capital Acquisition Corp., a Delaware corporation (now known as Xynomic Pharmaceuticals Holdings, Inc., the "Company"), par value $0.001 per share pursuant to a Backstop and Subscription Agreement dated May 1, 2019 between the Company and Yiling Mark Xu and converted its $500,000 promissory notes issued by the Company into 55,000 common shares and 25,000 warrants, each exercisable to purchase one share of common stock at $11.50 per whole share. Pursuant to the promissory note and warrant agreement, each unit consists of one share; each whole warrant entitles the holder to one common share exercisable at $11.50 per share, expiring at the 5th anniversary of the business combination. Fengyun Jiang, who has 100% ownership interest in Bison Capital and is Peixin Xu's spouse, has voting and dispositive power over the shares held by such entity. Mr. Xu was the Chairman of the Company but resigned at the closing of a business combination, effective May 15, 2019. /s/ Peixin Xu 2019-05-21